Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. NC3235788

MALIX LLC Status BTA (25 Tests)A Rapid Test For the Qualitative Detection of Bladder Tumor Associated Antigenin Human Urine

Supplier:  MALIX LLC STATBTA

Encompass_Preferred

Status BTA (25 Tests)
The test is indicated for use as an aid in the management of bladder cancer patients in conjunction with cystoscopy. The simple urine sample collection also allows for improved patient comfort. Because tumor markers can be used to assess the response of a tumor treatment and for prognosis, rapid screening tests like the Status BTA product are very helpful in the treatment management of cancer patients.
Key Features:
CLIA Waived
Results available in 5 minutes
Simple procedure requires only adding 3 drops of urine to test device; no sample preparation needed
Accurate test results with excellent sensitivity and specificity
Uses monoclonal antibodies to detect the presence of bladder tumor-associated antigen in urine
Detects early state recurrence cancer that cytology may miss
Adjunct test to cystoscopy

Catalog No. NC3235788


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.